A nonsense mutation in the SCN9A gene in congenital insensitivity to pain

Dermatology

Volumn 221, Issue 2, 2010, Pages 179-183

  Kurban, Mazen ^a   Wajid, Muhammad ^a   Shimomura, Yutaka ^a   Christiano, Angela M ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Anosmia; Erythromelalgia; Na1.7 channels; SCN9A gene

Indexed keywords

DNA;

ARTICLE; CLINICAL ARTICLE; CONGENITAL ANALGESIA; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE SEQUENCE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; MALE; MISSENSE MUTATION; NONSENSE MUTATION; PRIORITY JOURNAL;

CODON, NONSENSE; CONSANGUINITY; FEMALE; HUMANS; MALE; PAIN INSENSITIVITY, CONGENITAL; SODIUM CHANNELS;

EID: 77956339089     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314692     Document Type: Article

References (25)

1. Waxman SG: The neuron as a dynamic electrogenic machine: modulation of sodiumchannel expression as a basis for functional plasticity in neurons. Philos. Trans R Soc Lond B Biol Sci 2000; 355: 199-213.
2. Isom LL: Sodium channel b subunits: anything but auxiliary. Neuroscientist 2001; 7: 42-54.
3. Suls A, Claeys KG, Goossens D, et al: Microdeletions involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patients. Hum Mutat 2006; 27: 914-920.
4. Sugiura Y, Makita N, Li L, et al: Cold induces shifts of voltage dependence in mutant SCN4A, causing hypokalemic periodic paralysis. Neurology 2003; 61: 914-918.
5. Keller DI, Huang H, Zhao J, et al: A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and feverinduced ventricular fibrillation. Cardiovasc Res 2006; 70: 521-529.
6. Trudeau MM, Dalton JC, Day JW, et al: Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation. J Med Genet 2006; 43: 527-530.
7. Cox JJ, Reimann F, Nicholas AK, et al: An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006; 444: 894-898.
8. Drenth JP, te Morsche RH, Guillet G, et al: SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol 2005; 124: 1333-1338.
9. Fertleman CR, Baker MD, Parker KA, et al: SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006; 52: 767-774.
10. Nassar M A, Levato A, Stirling LC, et al: Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8. Mol Pain 2005; 1: 24.
11. Akopian AN, Souslova V, England S, et al: The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 1999; 2: 541-548.
12. Ahmad S, Dahllund L, Eriksson Ab, et al: A stop codon mutation in SCN9A causes lack of pain sensation. Hum Mol Genet 2007; 16: 2114-2221.
13. Dib-Hajj SD, Cummins TR, Black JA, et al: Nav1.7 and human pain disorders. Trends Neurosci 2007; 30: 555-563.
14. Yang Y, Wang Y, Li S, et al: Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 2004; 41: 171-174.
15. Drenth JP: The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32. Am J Hum Genet 2001; 68: 1277-1282.
16. Nilsen KB, Nicholas AK, Woods CG, et al: Two novel SCN9A mutations causing insensitivity to pain. Pain 2009; 143: 155-158.
17. Goldberg YP, MacFarlane J, MacDonald ML, et al: Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 2007; 71: 311-319.
18. Cummins TR, Howe JR, Waxman SG: Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci 1998; 18: 9607-9619.
19. Renganathan M, Cummins TR, Waxman SG: Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. J Neurophysiol 2001; 86: 629-640.
20. Sangameswaran L: A novel tetrodotoxinsensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem 1997; 272: 14805-14809.
21. Harty TP, Dib-Hajj SD, Tyrrell L, et al: Nav1.7 mutant A863P in erythromelalgia: effects of altered activation and steady-state inactivation on excitability of nociceptive dorsal root ganglion neurons. J Neurosci 2005; 26: 12566-12575.
22. Han C: Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann Neurol 2006; 59: 553-558.
23. Drenth JP, Waxman SG: Mutations in sodium- channel gene SCN9A cause a spectrum of human genetic pain disorders. J Clin Invest 2007; 117: 3603-3609.
24. Lafreniere RG, MacDonald ML, Dube MP, et al: Study of Canadian Genetic Isolates: Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates. Am J Hum Genet 2004; 74: 1064-1073.
25. Hilz MJ: Assessment and evaluation of hereditary sensory and autonomic neuropathies with autonomic and neurophysiological examinations. Clin Auton Res Suppl 2002; 12: 33-43.